Edwards Lifesciences Research and Development Expenses 2010-2025 | EW
Edwards Lifesciences annual/quarterly research and development expenses history and growth rate from 2010 to 2025. Research and development expenses can be defined as an expense arising from studies and product development processes.
- Edwards Lifesciences research and development expenses for the quarter ending March 31, 2025 were $0.255B, a 0.82% decline year-over-year.
- Edwards Lifesciences research and development expenses for the twelve months ending March 31, 2025 were $1.051B, a 9.65% increase year-over-year.
- Edwards Lifesciences annual research and development expenses for 2024 were $1.053B, a 9.36% increase from 2023.
- Edwards Lifesciences annual research and development expenses for 2023 were $0.963B, a 14.14% increase from 2022.
- Edwards Lifesciences annual research and development expenses for 2022 were $0.844B, a 6.59% decline from 2021.
| Edwards Lifesciences Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024 | $1,053 |
| 2023 | $963 |
| 2022 | $844 |
| 2021 | $903 |
| 2020 | $761 |
| 2019 | $753 |
| 2018 | $622 |
| 2017 | $553 |
| 2016 | $442 |
| 2015 | $383 |
| 2014 | $347 |
| 2013 | $323 |
| 2012 | $291 |
| 2011 | $246 |
| 2010 | $204 |
| 2009 | $176 |
| Edwards Lifesciences Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2025-03-31 | $255 |
| 2024-12-31 | $270 |
| 2024-09-30 | $253 |
| 2024-06-30 | $273 |
| 2024-03-31 | $257 |
| 2023-12-31 | $215 |
| 2023-09-30 | $243 |
| 2023-06-30 | $244 |
| 2023-03-31 | $261 |
| 2022-12-31 | $131 |
| 2022-09-30 | $234 |
| 2022-06-30 | $251 |
| 2022-03-31 | $229 |
| 2021-12-31 | $233 |
| 2021-09-30 | $238 |
| 2021-06-30 | $225 |
| 2021-03-31 | $207 |
| 2020-12-31 | $196 |
| 2020-09-30 | $196 |
| 2020-06-30 | $182 |
| 2020-03-31 | $187 |
| 2019-12-31 | $194 |
| 2019-09-30 | $196 |
| 2019-06-30 | $192 |
| 2019-03-31 | $171 |
| 2018-12-31 | $163 |
| 2018-09-30 | $162 |
| 2018-06-30 | $154 |
| 2018-03-31 | $143 |
| 2017-12-31 | $147 |
| 2017-09-30 | $143 |
| 2017-06-30 | $134 |
| 2017-03-31 | $129 |
| 2016-12-31 | $115 |
| 2016-09-30 | $113 |
| 2016-06-30 | $113 |
| 2016-03-31 | $102 |
| 2015-12-31 | $98 |
| 2015-09-30 | $101 |
| 2015-06-30 | $98 |
| 2015-03-31 | $86 |
| 2014-12-31 | $84 |
| 2014-09-30 | $88 |
| 2014-06-30 | $89 |
| 2014-03-31 | $86 |
| 2013-12-31 | $79 |
| 2013-09-30 | $84 |
| 2013-06-30 | $81 |
| 2013-03-31 | $80 |
| 2012-12-31 | $75 |
| 2012-09-30 | $74 |
| 2012-06-30 | $74 |
| 2012-03-31 | $69 |
| 2011-12-31 | $61 |
| 2011-09-30 | $62 |
| 2011-06-30 | $65 |
| 2011-03-31 | $59 |
| 2010-12-31 | $56 |
| 2010-09-30 | $53 |
| 2010-06-30 | $51 |
| 2010-03-31 | $45 |
| 2009-12-31 | $88 |
| 2009-09-30 | $45 |
| 2009-06-30 | $43 |
| 2009-03-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $45.878B | $5.440B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $191.291B | 83.79 |
| Thermo Fisher Scientific (TMO) | United States | $154.123B | 18.64 |
| Alcon (ALC) | Switzerland | $43.312B | 29.27 |
| IDEXX Laboratories (IDXX) | United States | $42.730B | 49.10 |
| DexCom (DXCM) | United States | $33.851B | 52.32 |
| IQVIA Holdings (IQV) | United States | $27.242B | 15.26 |
| Mettler-Toledo (MTD) | United States | $24.618B | 29.28 |
| STERIS (STE) | Ireland | $23.490B | 25.87 |
| Waters (WAT) | United States | $20.972B | 29.59 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.819B | 0.00 |
| Hologic (HOLX) | United States | $14.487B | 15.74 |
| Sysmex ADR (SSMXY) | Japan | $10.827B | 30.71 |
| Penumbra (PEN) | United States | $9.930B | 77.94 |
| Masimo (MASI) | United States | $9.120B | 33.64 |
| Globus Medical (GMED) | United States | $7.933B | 18.90 |
| Glaukos (GKOS) | United States | $5.795B | 0.00 |
| Teleflex (TFX) | United States | $5.279B | 8.71 |
| TransMedics (TMDX) | United States | $4.446B | 96.65 |
| Integer Holdings (ITGR) | United States | $4.276B | 22.41 |
| PROCEPT BioRobotics (PRCT) | United States | $3.149B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.495B | 14.85 |
| Veracyte (VCYT) | United States | $2.144B | 30.09 |
| Nihon Kohden (NHNKY) | Japan | $2.041B | 23.41 |
| Elekta AB (EKTAY) | Sweden | $1.933B | 17.38 |
| Alphatec Holdings (ATEC) | United States | $1.620B | 0.00 |
| Artivion (AORT) | United States | $1.332B | 124.76 |
| Tandem Diabetes Care (TNDM) | United States | $1.262B | 0.00 |
| OPKO Health (OPK) | United States | $1.047B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.014B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.955B | 5.08 |
| SiBone (SIBN) | United States | $0.785B | 0.00 |
| IRadimed (IRMD) | United States | $0.774B | 39.25 |
| Beta Bionics (BBNX) | United States | $0.653B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.565B | 8.78 |
| Mesa Laboratories (MLAB) | United States | $0.538B | 12.62 |
| OrthoPediatrics (KIDS) | United States | $0.519B | 0.00 |
| RxSight (RXST) | United States | $0.515B | 0.00 |
| AxoGen (AXGN) | United States | $0.478B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.473B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.435B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.429B | 11.42 |
| AngioDynamics (ANGO) | United States | $0.397B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.387B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.362B | 0.00 |
| NeuroPace (NPCE) | United States | $0.351B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.330B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.253B | 0.00 |
| 908 Devices (MASS) | United States | $0.241B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.240B | 14.56 |
| Neuronetics (STIM) | United States | $0.232B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.222B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.209B | 0.00 |
| Inogen (INGN) | United States | $0.190B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.157B | 0.00 |
| CVRx (CVRX) | United States | $0.152B | 0.00 |
| LENSAR (LNSR) | United States | $0.150B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.146B | 0.00 |
| Accuray (ARAY) | United States | $0.142B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.127B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.114B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.104B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.091B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.080B | 48.60 |
| EnVVeno Medical (NVNO) | United States | $0.071B | 0.00 |
| InspireMD (NSPR) | United States | $0.070B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.062B | 0.00 |
| Hyperfine (HYPR) | United States | $0.058B | 0.00 |
| Spectral AI (MDAI) | United States | $0.054B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.026B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.12 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |